|0.3390||+0.0440||+14.92%||Vol 2.66M||1Y Perf -78.15%|
|Aug 11th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||1.88||Analyst Rating||Strong Buy 1.00|
|Potential %||454.57||Finscreener Ranking||★★★★+ 56.84|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 57.85|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 50.47|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||5.16||Earnings Rating||Sell|
|Market Cap||63.73M||Earnings Date||8th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.08|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||2.46M|
|Avg. Monthly Volume||1.14M|
|Avg. Quarterly Volume||828.39K|
Conformis Inc. (NASDAQ: CFMS) stock closed at 0.339 per share at the end of the most recent trading day (a 14.92% change compared to the prior day closing price) with a volume of 2.66M shares and market capitalization of 63.73M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 271 people. Conformis Inc. CEO is Mark A. Augusti.
The one-year performance of Conformis Inc. stock is -78.15%, while year-to-date (YTD) performance is -55.48%. CFMS stock has a five-year performance of -90.56%. Its 52-week range is between 0.251 and 1.955, which gives CFMS stock a 52-week price range ratio of 5.16%
Conformis Inc. currently has a PE ratio of -6.80, a price-to-book (PB) ratio of 0.59, a price-to-sale (PS) ratio of 1.17, a price to cashflow ratio of 27.70, a PEG ratio of 2.32, a ROA of -5.20%, a ROC of -4.29% and a ROE of -8.24%. The company’s profit margin is -91.37%, its EBITDA margin is 0.80%, and its revenue ttm is $45.23 Million , which makes it $0.24 revenue per share.
Of the last four earnings reports from Conformis Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Conformis Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Conformis Inc. is Strong Buy (1), with a target price of $1.88, which is +454.57% compared to the current price. The earnings rating for Conformis Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Conformis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Conformis Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 12.53, ATR14 : 0.03, CCI20 : 278.68, Chaikin Money Flow : -0.36, MACD : -0.01, Money Flow Index : 76.44, ROC : 24.63, RSI : 54.90, STOCH (14,3) : 77.60, STOCH RSI : 1.00, UO : 47.02, Williams %R : -22.40), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Conformis Inc. in the last 12-months were: Mark A. Augusti (Sold 137 598 shares of value $137 021 ), Robert S. Howe (Sold 11 537 shares of value $7 514 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.